Close

Dr. Reddy's Laboratories Announces the Launch of Lansoprazole DR Orally Disintegrating Tablets in the U.S. Market

Go back to Dr. Reddy's Laboratories Announces the Launch of Lansoprazole DR Orally Disintegrating Tablets in the U.S. Market
DR. REDDY'S LAB LTD ADR (NYSE: RDY) Delayed: 71.25 +0.34 (0.48%)
Previous Close $70.91    52 Week High $54.73 
Open $70.90    52 Week Low $40.68 
Day High $71.30    P/E N/A 
Day Low $70.72    EPS $0.00 
Volume 89,244